Your browser doesn't support javascript.
loading
Modification to Systemic Anticancer Therapy at the Start of the COVID-19 Pandemic and its Overall Impact on Survival Outcomes in Patients with Colorectal Cancer.
Kamposioras, Konstantinos; Lim, Kok Haw Jonathan; Williams, Joseph; Alani, Mohammed; Barriuso, Jorge; Collins, Joanne; Marti, Kalena; Braun, Michael; Mullamitha, Saifee; Hasan, Jurjees; Alam, Nooreen; Mahmood, Sophina; Finch, Spencer; Bayles, Lauren; King, Jennifer; Saunders, Mark.
Afiliação
  • Kamposioras K; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom. Electronic address: konstantinos.kamposioras@nhs.net.
  • Lim KHJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Williams J; Department of Pharmacy, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Alani M; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Barriuso J; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
  • Collins J; Department of Pharmacy, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Marti K; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Braun M; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Mullamitha S; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Hasan J; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Alam N; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Mahmood S; Department of Pharmacy, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Finch S; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Bayles L; Department of Pharmacy, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • King J; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Saunders M; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
Clin Colorectal Cancer ; 21(2): e117-e125, 2022 06.
Article em En | MEDLINE | ID: mdl-34953674
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / COVID-19 Tipo de estudo: Guideline / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Colorectal Cancer Assunto da revista: GASTROENTEROLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / COVID-19 Tipo de estudo: Guideline / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Colorectal Cancer Assunto da revista: GASTROENTEROLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article